Cargando...

A review of pulmonary arterial hypertension: role of ambrisentan

Pulmonary arterial hypertension (PAH) is a rare fatal disease. Current disease-specific therapeutic interventions in PAH target 1 of 3 established pathways in disease pathobiology: prostacyclin, nitric oxide, and endothelin-1. Endothelin receptor antagonists (ERAs) act on the endothelin pathway by b...

Descrición completa

Gardado en:
Detalles Bibliográficos
Autor Principal: Barst, Robyn J
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2007
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1994051/
https://ncbi.nlm.nih.gov/pubmed/17583171
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!